Interestingly, when analyzing the ctDNA monitoring of each mutation, we found that the mean MAF of TERT c.-124C>T 4 and 12 months after RC was significantly higher in progressive than in non-progressive patients and in those patients who died due to BC. The gene discussed is TERT; the disease is breast cancer.